Key result
Higher platelet-to-lymphocyte ratio linked to ~2% higher odds of LAA thrombogenic milieu in AF.
Why the study?
The diagnostic value of the platelet to lymphocyte ratio regarding the risk of left atrial appendage thrombogenic milieu in patients with nonvalvular AF had not been studied.
Does the platelet to lymphocyte ratio predict the risk of left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation?
Observational (n=120)
No
Does the platelet to lymphocyte ratio predict the risk of left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation?
This study investigates the novel use of the platelet to lymphocyte ratio as a diagnostic marker for left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation.
Hypothesis-generating for PLR in LAA thrombus risk stratification in non-valvular AF; prospective validation needed before clinical use.
Objectives: To assess the diagnostic value of platelet to lymphocyte ratio (PLR) with respect to the risk of left atrial appendage thrombogenic milieu (LAA TM) in patients with nonvalvular atrial fibrillation (AF), which has not been studied before. Materials and Methods:This is a retrospective study that included consecutive patients with non-valvular AF who underwent transesophageal echocardiography (TEE) prior to electrical cardioversion or prior to AF catheter ablation.The potential association between PLR and LAA TM, which was defined as the presence of a thrombus, sludge and spontaneous echo contrast in LAA, was analyzed using multivariate logistic regression analysis.Results: A total of 120 patients (59 females, mean age: 66.15 ± 10.2 years) with nonvalvular AF were included in the study.The thrombogenic milieu was determined in 37 (30.83%)patients on TEE examination.Patients with LAA TM were found to have a higher mean CHA2DS2-VASc score (3.00 vs. 2.00, p=0.009), decreased LAA velocity (23.60 vs. 36.20m/s, p=0.002) and left ventricular ejection fraction (49.70 vs. 56.90%, p=0.010), greater left atrial diameter (4.70 vs. 4.30 cm, p= 0.001) and higher PLR value (157.91 vs. 126.13,p=0.023) compared to those without thrombogenic milieu.Only LAA velocity (OR=0.854;p=0.001) and PLR (OR=1.024;p=0.012) were found to be independently associated with LAA TM.Conclusion: PLR may be an independent risk factor for LAA TM in nonvalvular AF patients; however, beyond research purposes, the rather low sensitivity and specificity values must be interpreted with caution in the routine clinical setting.
No takes yet. Share an insight, caveat, or question.
Tek et al. (2022) conducted an observational in Non-valvular atrial fibrillation (n=120). Platelet to lymphocyte ratio (PLR) vs. Patients without left atrial appendage thrombogenic milieu (LAA TM) was evaluated on Left atrial appendage thrombogenic milieu (LAA TM), defined as the presence of thrombus, sludge, dense spontaneous echo contrast in LAA, or LAA flow velocity <=20 m/s (OR 1.024, 95% CI 1.005-1.042, p=0.012). Platelet to lymphocyte ratio was independently associated with left atrial appendage thrombogenic milieu in non-valvular AF patients (OR 1.024, 95% CI 1.005-1.042, p=0.012).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: